Statins are of unquestioned value in the prevention of cardiovascular events and are used by increasing numbers of people. However, when new data emerges on their unwanted effects, it is crucial that they are incorporated into the product information so that prescribers and patients can assess benefits and risks of treatment. This has yet to happen with regards to the knowledge that …